MoneyWorks4Me

Welcure Drugs&Pharma - Quaterly Results

02 Jul 2024 Evaluate
Revenue reduced marginally to stand at Rs. 0.00 millions during the quarter ended March 2024. The figure stood at Rs. 0.00 millions during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -0.18 millions as compared to Net Profit of Rs. 1.67 millions of corresponding quarter ended March 2023A decline of 0.03 millions was observed in the OP in the quarter ended March 2024 from 1.70 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.56 2.21 -74.66 0.94 2.37 -60.34 0.94 2.37 -60.34
PBIDT 0.03 1.70 -98.24 -1.39 1.05 -232.38 -1.39 1.05 -232.38
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 0.03 1.70 -98.24 -1.39 1.05 -232.38 -1.39 1.05 -232.38
Depreciation 0.21 0.03 600.00 0.36 0.03 1100.00 0.36 0.03 1100.00
PBT -0.18 1.67 -110.78 -1.75 1.02 -271.57 -1.75 1.02 -271.57
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.18 1.67 -110.78 -1.75 1.02 -271.57 -1.75 1.02 -271.57
Equity 134.39 134.39 0.00 134.39 134.39 0.00 134.39 134.39 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers